切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2014, Vol. 02 ›› Issue (01) : 32 -37. doi: 10.3877/cma.j.issn.2095-5820.2014.01.007

实验研究

B淋巴细胞刺激因子及其受体与非霍奇金淋巴瘤的关联性
申娴娟1, 王梅2, 鞠少卿3,()   
  1. 1.226001 江苏省南通大学附属医院外科综合实验室
    2.江苏省南通大学
    3.江苏省南通大学附属医院医学检验中心
  • 收稿日期:2013-07-25 出版日期:2014-02-28
  • 通信作者: 鞠少卿
  • 基金资助:
    国家自然科学基金资助项目(81271920、81301498)江苏“科教兴卫工程”医学创新团队项目资助课题(LJ201133)

The clonocal relevance of B lymphocyte stimulating factor and its receptors to the non-Hodgkin's lymphoma

Xianjuan Shen1, mei Wang2, Shaoqing Ju3,()   

  1. 1.Surgical Comprehensive Laboratory, Affiliated Hospital of Nantong University, Nantong 226001, China
    2.Affiliated Hospital of Nantong University, Nantong 226001, China
    3.Laboratory Medicine Center, Affiliated Hospital of Nantong University,Nantong 226001, China
  • Received:2013-07-25 Published:2014-02-28
  • Corresponding author: Shaoqing Ju
引用本文:

申娴娟, 王梅, 鞠少卿. B淋巴细胞刺激因子及其受体与非霍奇金淋巴瘤的关联性[J/OL]. 中华临床实验室管理电子杂志, 2014, 02(01): 32-37.

Xianjuan Shen, mei Wang, Shaoqing Ju. The clonocal relevance of B lymphocyte stimulating factor and its receptors to the non-Hodgkin's lymphoma[J/OL]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2014, 02(01): 32-37.

目的

探讨B淋巴细胞刺激因子(B lymphocyte stimulating factor,BLyS/BAFF)及其受体在非霍奇金淋巴瘤(non-Hodgkin lymphoma,NHL)中的表达及其与NHL的关联性。

方法

采用成组配对试验诊断研究设计。用ELISA和实时荧光定量PCR测定47例NHL患者及20名健康人血清BAFF及其受体含量和外周血单个核细胞(peripheral blood mononuclear cell,PBMC)中BAFF mRNA 含量;并用配对t检验比较分析两组血清BAFF及其受体蛋白或BAFF mRNA表达水平差异,同时分析其与乳酸脱氢酶(lactate dehydrogenase,LDH)、β2微球(β2-microglobulin,β2M)间的相关性。

结果

NHL组PBMC中BAFF mRNA含量(0.48±0.02)显著高于健康对照组(0.25±0.02,t=17.75,P=0.000);NHL组血清BAFF及其受体TACI、BCMA、BAFF-R表达水平[(19.18±1.29) ng/ml、(212.74±7.98) pg/ml、(102.98±6.18) pg/ml、(2.95±0.19) ng/ml]也均较健康人明显增高[(10.94±1.56) ng/ml、(139.00±12.51) pg/ml、(59.66±7.06) pg/ml、(1.34±0.26) ng/ml,t值分别为7.05、8.61、7.99、8.66,P均<0.01]。NHL患者中LDH升高组[(310.96±108.00)U/L]显著高于LDH正常组[(142.65±36.00) U/L],且两组间差异有统计学意义(t=4.697,P<0.05)。LDH升高组NHL患者血清BAFF、BCMA蛋白水平、BAFF mRNA表达水平与LDH正常组的差异均有统计学意义(t值分别为21.060,7.254,6.658;P均<0.05)。但NHL组BAFF mRNA、血清BAFF及其受体蛋白表达水平与β2M、LDH含量间无直线相关性(r值分别为0.026、0.014、0.127、0.001、0.003与0.201、0.093、0.015、0.031、0.169;P均>0.05)。

结论

NHL患者PBMC中BAFF mRNA和血清BAFF及其受体蛋白表达水平均升高,BAFF及其受体可能是参与NHL发病的因素,其表达水平与疾病的活动性有关。

Objective

To measure the levels of B lymphocyte stimulating factor (BLyS/BAFF)and its receptors in non-Hodgkin's lymphoma (NHL) and to determine the relationship between BAFF and receptors level with NHL.

Methods

Serum levels of BAFF, its receptor and blood mononuclear cell(PBMC) BAFF mRNA levels of 47 NHL patients and 20 controls were determined by ELISA and real-time quantitative PCR. Paired-samples t test was used to compare the differences of serum BAFF, its receptor and BAFF mRNA levels between NHL patients and healthy controls. Meanwhile, the correlations between the expression of BAFF and its receptors and the concentration of lactate dehydrogenase (LDH), β2-microglobulin(β2M) were estimated.

Results

Compared with controls, NHL patients had significantly higher levels of BAFF PBMC mRNA (0.48±0.02 vs. 0.25±0.02, t=17.75, P=0.000). Serum BAFF and its receptors TACI,BCMA, BAFF-R levels in NHL patients [(19.18±1.29) ng/ml, (212.74±7.98) pg/ml, (102.98 ±6.18) pg/ml,(2.95±0.19) ng/ml] were significantly higher than those in healthy controls [(10.94±1.56) ng/ml,(139.00±12.51) pg/ml, (59.66±7.06) pg/ml, (1.34±0.26) ng/ml, t values were 7.05, 8.61, 7.99, 8.66,P<0.01]. Compared with the normal LDH group, the elevated LDH group had significantly higher levels of LDH [(310.96±108.00) U/L vs (142.65±36.00) U/L, t=4.697, P<0.05] , there were also significant differences in BAFF, BCMA and BAFF mRNA expression between the two groups (t values were 21.060, 7.254, 6.658, respectively, P<0.05). However, there was no significant correlation between BAFF mRNA, serum BAFF and its receptors and β2M, LDH (r=0.026, 0.014, 0.127, 0.001, 0.003;0.201, 0.093, 0.015, 0.031, 0.169, respectively, P>0.05).

Conclusion

Serum BAFF, and PMBC BAFF mRNA levels are significantly elevated in NHL patients, suggesting that BAFF and its receptors may be involved in the pathogenesis of NHL and those expression may associate with the activity of NHL.

表1 NHL组与健康对照组血清BAFF及其受体蛋白表达水平比较(
图1 NHL患者血清BAFF和受体蛋白浓度与BAFF mRNA表达水平的关联性
图2 BAFF mRNA表达水平、BAFF及其受体蛋白浓度与β2M浓度间的关联性
图3 NHL患者外周血BAFF mRNA表达水平、BAFF及其受体蛋白浓度与LDH浓度间的关联性
表2 LDH含量升高组与正常组NHL的BAFF蛋白和BAFF及其受体mRNA表达水平比较(
1
Moore PA, Belvedere O, Orr A, et al. BLys: member of the tumor necrosis factor family and B lymphocyte stimulator[J]. Science, 1999,285(5425): 260-263.
2
Hong SD, Reiff A, Yang HT, et al. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients[J]. Arthritis Rheum, 2009, 60(11): 3400-3409.
3
Ju S, Wang Y, Ni H, et al. Correlation of expression levels of BLyS and its receptors with multiple myeloma[J]. Clin Biochem, 2009,42(4-5): 387-399.
4
Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF)correlates with the titre of autoantibodies in human Sjogren's syndrome[J]. Ann Rheum Dis, 2003, 62(2): 168-171.
5
Lied GA, Berstad A. Functional and clinical aspects of the B-cellactivating factor (BAFF): a narrative review[J]. Scand J Immunol,2011, 73(1): 1-7.
6
Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group[J]. Blood, 1994, 84(5): 1361-1392.
7
Novak AJ, Grote DM, Stenson M, et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome[J]. Blood, 2004, 104(8): 2247-2253.
8
鞠少卿, 倪红兵, 王跃国, 等. 血清BLyS和APRIL水平与非霍奇金氏病关联性的初步研究[J]. 中国免疫学杂志, 2007, 23(10): 563-566.
[1] 葛飞霞, 蒋银, 杨丹. 酶联免疫吸附测定法与PCR仪检测在乙型肝炎诊断中的临床应用[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(04): 310-315.
[2] 铁晓玲, 刘毅, 杨颖, 车凤玉. Rubinstein-Taybi综合征先证者3例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 452-459.
[3] 郭静, 田国力, 王燕敏, 周卓, 纪伟. 葡萄糖-6-磷酸脱氢酶缺乏症新生儿葡萄糖-6-磷酸脱氢酶及其基因突变的研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2020, 16(06): 672-679.
[4] 贾赤宇, 毛舒婷. 困惑、挑战与希望[J/OL]. 中华损伤与修复杂志(电子版), 2020, 15(06): 423-427.
[5] 丁科, 张亚琼, 刘杰, 邓莉平, 张永喜, 熊勇. 获得性免疫缺陷综合征相关淋巴瘤患者的临床特征及生存状况的变化趋势[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 278-284.
[6] 王俊文, 田原, 范子豪, 徐玲, 高耀, 曹亚玲, 潘桢桢, 张向颖, 宋岩, 任锋. 基于规律成簇的间隔短回文重复序列及其相关蛋白技术检测乙型肝炎病毒共价闭合环状DNA方法的建立[J/OL]. 中华实验和临床感染病杂志(电子版), 2022, 16(05): 320-327.
[7] 佟晔, 张昕宇, 周志安, 王立东. 以非伤寒沙门菌菌血症首诊的非霍奇金淋巴瘤一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2020, 14(02): 167-171.
[8] 欧阳航, 陈德波, 骆时木, 杨培东, 蒋燕成, 张志珊. 乳腺癌相关基因CK19与Vimentin mRNA联合检测在乳腺癌中的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(04): 422-425.
[9] 罗来邦, 王绪杨, 胡续光, 张友福, 徐志丹. 宏基因组二代测序早期筛查肝移植术后人类微小病毒B19感染临床研究[J/OL]. 中华移植杂志(电子版), 2022, 16(06): 346-352.
[10] 李协照, 徐桂彬, 袁耀基, 蔡志煅, 朱锐, 梁斯扬, 庄浩铨, 李逊. 上尿路结石合并血液肿瘤的诊治体会(附13例报告)[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(06): 493-496.
[11] 王尚, 项丽, 许国双. B淋巴细胞在狼疮性肾炎中的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2020, 09(04): 181-185.
[12] 苏元波, 李其辉, 李璐, 路明, 董菲. 免疫化疗对HBsAg阴性/抗-HBc阳性T细胞非霍奇金淋巴瘤患者乙型肝炎病毒再激活的影响[J/OL]. 中华临床医师杂志(电子版), 2024, 18(01): 1-6.
[13] 郑婉珊, 殷茵, 涂兆伟, 曹彬. 选择适用于研究滋养层细胞合体化过程的内参基因的实验研究[J/OL]. 中华产科急救电子杂志, 2022, 11(01): 46-52.
[14] 龚文娟, 陈宝荣, 孙慧颖, 郑燕华. 新型冠状病毒核酸检测阳性质控品污染原因分析及解决办法[J/OL]. 中华临床实验室管理电子杂志, 2021, 09(04): 237-241.
[15] 余娟平, 李志强, 李龙, 魏琦, 都伟杰, 毕真, 李芳云, 方琼, 陈浩, 陈良军, 康卫灵, 王智慧, 蔡维文, 殷梅梅, 方婷, 王倩倩, 梅圣学, 李强, 常中宝, 申梦来, 程雅婷, 李晓华. 对新型冠状病毒核酸检测低基因扩增信号样本的再分析[J/OL]. 中华临床实验室管理电子杂志, 2021, 09(04): 231-236.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?